INTRODUCTION
The liver fatty-acid-binding protein (L-FABP) is a 14 kDa cytoplasmic protein that binds long-chain fatty acids (LCFAs) with high affinity [1] . The putative functions assigned to L-FABP include the desorption of LCFAs from the plasma membrane to the cytoplasm, the promotion of intracellular fatty acid (FA) diffusion, the targeting of FAs to different metabolic pathways and protection against the cytotoxic effects of free FA (reviewed in [2] ). Roles in signal transduction pathways and gene regulation have also been reported [3] [4] [5] . The involvement of L-FABP in the metabolic adaptation to changes in lipid content of the diet can therefore be envisaged in tissues in which it is expressed at substantial levels (i.e. small intestine and liver). Drugs that affect either lipid metabolism or the lipid content of the diet modulate L-FABP gene expression in these tissues. Indeed, it has been shown that both fibrate hypolipidaemic drugs and LCFAs enhance the transcription rate of the gene encoding L-FABP [6] [7] [8] [9] . It is well established that fibrates and LCFAs regulate gene expression through the activation of nuclear receptors termed peroxisome-proliferator-activated receptors (PPARs) [10] . PPARs bind as heterodimers with the retinoid X receptor Abbreviations used : ACS, acyl-CoA synthase ; A-FABP, adipocyte fatty-acid-binding protein ; CAT, chloramphenicol acetyltransferase ; DEHP, di-2-ethylhexyl phthalate ; FA, fatty acid ; FAT/CD36, fatty-acid translocase ; L-FABP, liver fatty-acid-binding protein ; LCFA, long-chain fatty acid ; NaT, sodium taurocholate ; PPAR, peroxisome-proliferator-activated receptor ; PPRE, peroxisome-proliferator-responsive element ; PUFA, polyunsaturated fatty acid ; RXR, retinoid X receptor ; tk, herpesvirus thymidine kinase. 1 Present address : Laboratoire Central de Chimie Clinique, Ho# pital Universitaire, CH-1011 Lausanne, Switzerland. 2 To whom correspondence should be addressed (e-mail pbesnard!u-bourgogne.fr).
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fibrate-mediated effects on L-FABP mRNA levels in wild-type and PPARα-null mice, we have found that PPARα in the intestine does not constitute a dominant regulator of L-FABP gene expression, in contrast with what is known in the liver. Only the PPARδ\α agonist GW2433 is able to up-regulate the gene encoding L-FABP in the intestine of PPARα-null mice. These findings demonstrate that PPARδ can act as a fibrate\FA-activated receptor in tissues in which it is highly expressed and that L-FABP is a PPARδ target gene in the small intestine. We propose that PPARδ contributes to metabolic adaptation of the small intestine to changes in the lipid content of the diet.
Key words : lipid homoeostasis, PPARα-null mice, PPARδ.
(RXR) to a specific DNA sequence termed the peroxisomeproliferator-responsive element (PPRE) located upstream of target genes that are involved mainly in lipid metabolism [11] . A PPRE has been identified in the proximal 5h flanking region (position k67\k55) of the gene encoding L-FABP in rodents [12, 13] . In itro this PPRE L−FABP sequence permits the efficient binding of complexes between the different PPAR subtypes (α, γ and δ) and RXRs [14, 15] . Moreover, it seems to be functional in i o because transgenic mice expressing only the short L-FABP promoter (k132\j21) sequence, in which the PPRE is found, are able to reproduce the fibrate-mediated induction of the gene for L-FABP in the liver [13] . The targeted disruption of the gene encoding PPARα fully abolishes the hepatic induction by fibrates of the gene for L-FABP [16] . This last result demonstrates that PPARα is crucial for the fibrate action in this organ. In contrast, although LCFAs and their metabolites have been reported to be activators of PPARs [17] [18] [19] , the molecular mechanism by which they up-regulate L-FABP gene expression remains to be established. Moreover, no information is available for the small intestine, where the gene encoding L-FABP is also highly expressed and is thought to be involved in FA absorption. PPARδ is especially highly expressed in enterocytes, in contrast with hepatocytes, where the dominant subtype is PPARα [20] . These differences in tissue expression raise the question of the respective roles of these two PPAR subtypes in the regulation of the gene for L-FABP in the small intestine and the liver. To explore the molecular mechanism involved in the cellular trafficking of LCFAs in both the small intestine and liver, the contribution of PPARα and PPARδ to the regulation of L-FABP gene expression was studied in itro by transfection assays and in i o with the help of PPARα-deficient mouse model [16] . In contrast with results from the liver, our results for the small intestine demonstrate that PPARα is not required there for the fibrate\FA-mediated inductions of the gene encoding L-FABP, which seems to be a PPARδ target gene in this organ.
MATERIALS AND METHODS

Animals and experimental treatments
French guidelines for the use and care of laboratory animals were followed. The male homozygous PPARα-deficient mice of C57BL\6 genetic background were used [16] . Age-matched wildtype male C57BL\6 mice, purchased from CERJ (Le Genest, France) were used as PPARα +/+ controls. Animals were housed individually in a controlled environment (constant temperature and humidity, darkness from 08 : 00 h to 20 : 00 h). They were fed ad libitum with a standard chow containing 8 % (w\v) lipid in total calories (UAR A-04 ; Usine d'alimentation rationnelle, Epinay sur Orge, France).
To study the involvement of PPARα in fibrate-mediated induction of the gene encoding L-FABP, C57BL\6 wild-type and PPARα-deficient mice were fed for 7 days with a laboratory chow containing 0.5 % (w\v) bezafibrate. This synthetic hypolipidaemic agent was chosen because it elicits the transcription of the gene for L-FABP in the small intestine [7] . The up-regulation of L-FABP expression by FAs was also checked in PPARα +/+ and PPARα −/− mice either force-fed for 5 days with 0.2 ml of sunflower oil to provide 16 % of total calories in lipids (compared with 8 % in the control diet) or with a laboratory chow containing 30 % sunflower oil (in total calories). In the force-feeding experiment, controls received in the same manner 0.2 ml of 0.15 M NaCl. Sunflower oil is characterized by its high content of linoleic acid.
In adult C57BL\6, the length of the small intestine was approx. 35 cm. To study accurately the expression of L-FABP and PPARs along the gut, the small intestine was divided into seven segments of 5p0.3 cm from the pylorus to the ileocaecal valvula. It is usually stated that the jejunum starts only after Treitz's ligament. Because it starts approx. 7 cm from the pylorus in the strain that we used, the first 10 cm (segments 1 and 2) were arbitrarily considered to be the duodenum, the next 15 cm (segments 3-5) the jejunum and the last 10 cm (segments 6 and 7) the ileum. After the animals had been killed, intestinal and hepatic samples were snap-frozen in liquid nitrogen and stored at k80 mC until required for RNA extractions.
The direct effect of the non-metabolizable LCFA α-bromopalmitate on L-FABP gene expression was checked with the use of the distal ileum model [7] . Anaesthetized PPARα +/+ and PPARα −/− mice were laparotomized ; they then received, by direct infusion into the distal part of the ileum (segment 7), 0.2 ml of α-bromopalmitate (10 µmol) emulsified with sodium taurocholate (α-bromopalmitate-to-NaT ratio 1 : 2). Animals were quickly sutured and kept in individual cages. Controls were treated with the vehicle alone (20 µM NaT) by the same protocol. At 1 day after surgery, the entire ileum was removed, flushed with cold 0.15 M NaCl and a 5 cm segment was taken 1 cm above the caecum. The mucosa was scraped off with a spatula, frozen immediately in liquid nitrogen and stored at k80 mC until used for RNA extraction.
Organ culture of intestinal explants
PPARα +/+ and PPARα −/− mice were fasted overnight and duodeno-jejunal explants (i.e. segments 2 and 3) and ileal explants (segment 7) were prepared as described previously [21] . Explants were cultured at 37 mC under an oxygenated atmosphere in DMEM (Dulbecco's modified Eagle's medium) containing 10 % (v\v) NCTC-135, 10 % (v\v) fetal calf serum, 0.1 % Fungizone, 0.1 mg\ml gentamicin (all from Gibco BRL) and 0.7 i.u.\ml ribonuclease inhibitor from human placenta (Boehringer). After a 4 h preculture period, explants were cultured for 20 h in the presence of 50 µM bezafibrate, 1. 
Northern blotting
Total RNA species were extracted from liver and intestinal mucosa by the method of Chomczynski and Sacchi [22] . They were denatured, subjected to electrophoresis on a 1 % (w\v) agarose gel and transferred to Gene Screen membranes (NEN) as described previously [6] . Rat L-FABP [23] , mouse PPARα [10] , PPARδ [24] and β-actin [25] were used as probes. They were labelled with [α$#P]dCTP (3000 Ci\mmol ; Amersham) by a megaprime kit (Amersham). A 24-residue oligonucleotide specific for rat 18 S rRNA was used as probe to ensure that equivalent quantities of RNA were loaded and transferred. This oligonucleotide was 5h end-labelled with T % polynucleotide kinase and [γ $#P]ATP (3000 Ci\mmol ; Amersham).
Recombinant plasmids
The large promoter pL-FABP(k4000\j21)-tk-CAT (in which CAT stands for chloramphenicol acetyltransferase) was constructed by cloning the BamHI\HindIII-digested fragment of pLFhG4 plasmid [26] into pBL-tk-CAT8 + . The short promoter pL-FABP(k326\j21)-tk-CAT was generated by HindIII\NsiI digestion of the full-length L-FABP(k4000\j21) promoter. The pL-FABP(k4000\j21)-CAT plasmid was obtained by BamHI\BglII deletion of the herpesvirus thymidine kinase (tk) promoter from pL-FABP (k4000\j21)-tk-CAT. Mutations in the PPRE L-FABP (k67\k55) sequence were generated with the QuickChange4 mutagenesis kit (Stratagene). The following oligonucleotides were used : 5h-CGA CAA TCA CTG AGC GGC CGC CTA TAT TTG AGG AGG AAG AAG CCC-3h (PPRE L-FABP in bold ; mutations are underlined) and 5h-GGG CTT CTT CCT CCT CAA ATA TAG GCG GCC GCT CAG TGA TTG TCG-3h. Each of the mutated bases is either poorly represented or lacking in the native functional PPREs [27] . The different DNA constructs were analysed before use (T7 sequencing kit ; Pharmacia) to confirm the sequence and orientation of the insert.
The unpublished DNA sequence of the L-FABP promoter (nt k4000 to k597) was sequenced with the dideoxynucleotide procedure. The sequencing was undertaken from both sides of the promoter sequence, with specific oligonucleotides (28-30-mers) chosen every 250 nt along the progressively known sequence of the promoter. Regulation of liver fatty-acid-binding protein . Transcriptional activity is expressed as relative CAT activity normalized to β-galactosidase activity ; results are meanspS.E.M., n l 3. *P 0.05 ; **P 0.01, ***P 0.001. (B) The proximal PPRE sequence is functional and sufficient to reproduce the mediated induction of the gene encoding L-FABP in the presence of activated PPARs. Caco-2 cells were co-transfected with different constructs of the L-FABP promoter and mPPARα, mPPARδ and mPPARγ expression vectors activated by selective pharmacological agonists. Lane 1, the large k4000/j21 L-FABP construct containing the proximal PPREs ; lane 2, the k326/j21 L-FABP construct resulting from 5h end deletion of the large promoter ; lane 3, large construct k4000/j21 L-FABP in which the PPRE(k67/k55) sequence was mutated (mutation underlined). Cells were treated with 25 nM PPARα (GW7647), 25 nM PPARγ (GW7845) or 1.5 µM PPARδ/α (GW2433) agonist for 24 h. Results are expressed as fold induction relative to cells treated with the vehicle alone and are meanspS.E.M., n l 3.
Cell culture and transfection assays
Transient transfections were performed in undifferentiated human enterocyte-like Caco-2 cells (passages 53-60). They were cultured in 60 mm dishes at 37 mC under a humidified atmosphere [air\CO # (19 : 1)] in DMEM supplemented with 10 % (v\v) fetal calf serum, 4 mM -glutamine, 1 % non-essential amino acids, 50 mg\ml streptomycin and 200 i.u.\ml penicillin. At 1 day before transfection, Caco-2 cells were treated with 0.5 % trypsin\0.25 g\l EDTA, then replated in six-well plates. They were refed with medium supplemented with 10 % (v\v) delipidated fetal calf serum (Sigma) 4 h before transfection. Cells were typically co-transfected with 4 µg of the reporter pL-FABP-CAT or pL-FABP-tk-CAT gene constructs and, where indicated, with 0.5 µg of effector pSG5 plasmids expressing full-length cDNA species for mouse PPARα [10] , PPARδ [24] , PPARγ1 [28] or PSG5 alone. Plasmid CMVβ-Gal (cytomegalovirus promoter β-galactosidase) (1 µg) was included as an internal control for transfection efficiency. Transfection experiments were performed with the calcium phosphate method [29] . Experiments were conducted with 25 nM selective PPARα (GW7647) and PPARγ (GW7845) agonists and 1.5 µM dual agonist for PPARα and PPARδ (GW2433) (i.e. 5-fold the EC &! values of these compounds). Control cultures were performed with the vehicle alone [0.1 % (v\v) DMSO]. Cells were harvested 24 h after induction. Cellular extracts were prepared and assayed for β-galactosidase (β-Gal) and CAT activities [29] . All measurements were made in triplicate.
Statistical methods
Whenever possible, the results are expressed as meanspS.E.M. The significance of differences between groups was determined by Student's t test.
RESULTS
Linoleic acid induces the transcription of L-FABP gene promoter-reporter constructs
To demonstrate that the LCFA-regulated transcription of the gene encoding L-FABP requires PPARs, Caco-2 cells were transiently transfected with the large fragment (k4000\j21 bp) of rat L-FABP promoter cloned upstream of a tk-CAT reporter gene in the presence or absence of linoleic acid and expression vectors for mouse PPARα, PPARδ or PPARγ. The efficiency of transfections was assessed by co-transfection with the β-galactosidase expression vector and the assay of enzymic activity. The addition to the medium of 320 µM linoleic acid led to a weak but significant increase of the CAT activity ( Figure 1A) , suggesting that Caco-2 cells express low levels of endogenous PPARs. In contrast with PPARδ and PPARγ, transfection with the PPARα expression vector alone resulted in a strong stimulation of the reporter gene ( Figure 1A) . Similar results have been already reported for HeLa, CV1, NIH 3T3 and HepG2 cell lines [14, 30, 31] . It was probably due to the presence of specific endogenous activators for PPARα in the Caco-2 cells and\or the culture medium. Linoleic acid induced the transcriptional activity of the gene reporter system in the presence of the three PPAR expression vectors, the weakest effect being found with the γ subtype ( Figure 1A) . A higher transcriptional activation was found in cells co-transfected with both PPAR and RXRβ after addition to the culture medium of 320 µM linoleic acid and 1 µM 9-cis-retinoic acid (results not shown). This observation is consistent with studies in itro showing that only heterodimers between PPARα, PPARδ or PPARγ and RXRβ are able to bind specifically the PPRE already identified [14, 15] . Taken together, these results strongly suggest that the L-FABP promoter responds to fibrates and LCFAs through PPAR-RXR heterodimers. It is In the study in vivo, animals were fed for 7 days with a laboratory chow containing 0.5 % (w/v) bezafibrate (B). Controls (C) received a standard chow. Northern blot analysis of L-FABP mRNA levels in the liver and the proximal intestine (segments 1 and 2) was performed with 30 µg of total RNA. The bar graph representation was derived from four independent experiments and shows meanspS.E.M. *P 0.05, ***P 0.001. The study in vitro was performed in duodeno-jejunal explants (segments 2 and 3) from PPARα − / − and PPARα + / + mice, cultured for 20 h in presence of 50 µM bezafibrate (B). Control cultures (C) were performed with vehicle alone (0.15 % DMSO). L-FABP mRNA levels were analysed by Northern blotting (20 µg of total RNA). To demonstrate the specificity of the response, blots were reprobed with mouse β-actin cDNA. The results were normalized to 18 S rRNA to control for differences in RNA loading. PPARα + / + and PPARα − / − control mice were arbitrarily assigned the value 1. Filled bars, controls ; open bars, bezafibrate-treated mice.
noteworthy that the large fragment L-FABP promoter was also functional in the context of the natural promoter. Indeed, when the cells were transfected with PPARα expression vector in the presence of 50 µM bezafibrate, a similar CAT activity induction (1.6-fold) was found with the (k4000\j21)CAT and (k4000\j21)tk-CAT constructs. Regulation of liver fatty-acid-binding protein
Unique functional PPRE directs the gene encoding L-FABP
More than one functional PPRE has been identified in a few PPAR\RXR target genes [11] . The significance of such a redundant system is currently unclear. It might support a PPAR isotype selectivity. Indeed, a specific PPARδ-responsive element has recently been described [32] . To explore whether similar features are found in the L-FABP promoter, the unpublished DNA sequence from k4000 to k597 was sequenced and analysed (GenBank accession number AF329653). A second PPRE-like sequence (5h-AGAGCTaTGGCCTTGTTATC ; bold letters indicate identity with the ideal PPRE sequence ; italics indicate the flanking sequence [27] ) located at position k1616\k1597 bp upstream of the transcription site was identified by a computer search (Mat Inspector V2.2). To explore the functional role of this distal PPRE sequence, different constructs of L-FABP promoter containing either native or mutated proximal PPRE sequence were obtained by mutation or 5h-deletion of the long promoter (k4000\j21). In the presence of the pharmacological agonists GW7647, GW2433 or GW7845, which preferentially activate PPARα, PPARδ\α and PPARγ respectively, a significant transactivation was found when the reporter gene was driven by the native large construct. A similar induction was also found with the native short promoter (k326\j21). In contrast, transactivation was fully abolished when the PPRE sequence located at position k67\k55 was mutated ( Figure 1B ). These results demonstrate that the rat gene encoding L-FABP contains a unique functional PPRE located in the proximal part of the promoter. Moreover, this experiment yields a better characterization of the responsiveness of the gene encoding L-FABP to the different PPARs by the use of selective agonists. As shown in Figure 1(B) , all PPAR subtypes activated the reporter gene, in good agreement with the ability of various PPARs to bind the proximal PPRE L-FABP in itro [14, 15] . The strongest transactivation occurred with PPARδ activated by GW2433.
PPARα is not required for bezafibrate or FA inductions of the gene encoding L-FABP in the small intestine
The magnitude of induction of PPAR-responsive genes is influenced not only by the PPAR ligand specificity but also by the ratio of the expression of the three PPAR isoforms. In the liver, the PPARα subtype is the most highly expressed. In contrast, it is found at low levels in the small intestine, where the PPARδ isoform is predominant and PPARγ is undetectable [20] . To determine the relative contributions of PPARα and PPARδ subtypes in the fibrate-and LCFA-mediated regulation of the gene encoding L-FABP in i o, PPARα-null (PPARα −/− ) mice were subjected to treatment with bezafibrate or high-fat diets, enriched in linoleic acid. In the small intestine, L-FABP mRNA levels were not significantly changed by disruption of the gene encoding PPARα, with the exception of the proximal duodenum, where the concentration was lower in PPARα-null mice ( Figure  2 ). After reaching a maximum of expression in the distal duodenum, L-FABP decreased progressively, falling to undetectable levels in the distal ileum (segment 7). This pattern of expression is in agreement with previously published results [9] . In both PPARα +/+ and PPARα −/− mice, the highest PPARδ mRNA levels occurred in the duodenum, decreased progressively in the jejunum, and were slightly increased in the distal ileum (Figure 2) . Bezafibrate treatment or high-fat diet did not modify the PPARδ mRNA levels along the small intestine in control or PPARα-null mice (results not shown).
In agreement with previous reports [6, 7] , significant increases in both intestinal and hepatic L-FABP mRNA levels were Mice were fed ad libitum with a standard chow containing 8 % of total calories in lipids. Mice subjected to the high-fat diet containing 16 % total calories in lipids were daily force-fed in the morning for 5 days with 0.2 ml of sunflower oil (SFO). The controls (C) received in the same manner 0.2 ml of 0.15 M NaCl. Mice exposed to the very-high-fat diet were fed for 5 days with a laboratory chow containing 30 % of total calories in sunflower oil. Northern blots were performed with 30 µg of total RNA. The effects of the dietary lipids on L-FABP mRNA levels were studied throughout the small intestine (from the pylorus to the ileo-caecal valvula). For the gut, the bar graphs represent the means of areas under the curves corresponding to the L-FABP expression. The results were normalized to 18 S rRNA to control for differences in RNA loading. PPARα + / + and PPARα − / − control mice were arbitrarily assigned the value 1. Black bars, controls ; white bars, high-fat diet containg 16 % of lipids ; grey bars, very-high-fat diet containing 30 % of lipids. Results are meanspS.E.M. for three or four independent experiments. *P 0.025 ; **P 0.01.
found in PPARα +/+ mice subjected to bezafibrate treatment ( Figure 3 ). As expected, and in agreement with Lee et al. [16] , the fibrate-mediated induction of the gene encoding L-FABP was fully abolished in the liver of PPARα-null mice. Surprisingly, the bezafibrate-mediated induction of the gene for L-FABP was maintained in the small intestine in PPARα −/− mice (Figure 3) . To verify this, the experiment was reproduced ex i o with duodeno-jejunal explants (i.e. intestinal segments 2 and 3). After 20 h of culture in presence of bezafibrate, 2.2-fold and 1.9-fold increases in L-FABP mRNA levels were found in PPARα +/+ and PPARα −/− mice respectively (Figure 3) . Thus, in contrast with the liver, PPARα expression is not absolutely required for induction of the gene encoding L-FABP by fibrates in the small intestine.
Similar results were found in mice subjected to high-fat diets containing either 16 % or 30 % lipids in total calories. As shown in Figure 4 , the increase in L-FABP mRNA levels in the liver of sunflower oil-fed mice was ablated in PPARα-null mice. In contrast, as found with bezafibrate treatment, disruption of the gene encoding PPARα did not suppress the well-known lipidmediated up-regulation of L-FABP gene expression in the small intestine [9] . To confirm this last result, infusions into terminal ileum were performed. In this model in i o, because the expression of the gene encoding L-FABP is undetectable in the distal intestine (Figure 2) , it can be highly induced when Figure 5 Ileal infusion of a LCFA triggers the appearance of L-FABP mRNA in PPARα − / − mice α-Bromopalmitate (α-BrPal) (10 µmol) complexed with NaT in a 1 : 2 ratio was infused directly into the distal ileum of PPARα + / + and PPARα − / − mice (segment 7). Controls received vehicle only (NaT) in the same manner. Total RNA species were extracted from ileal mucosa 24 h after surgery and analysed by Northern blotting. Shown is a typical Northern blot performed with 30 µg of total RNA. Results were normalized to 18 S rRNA to control for differences in RNA loading.
adequate stimuli are directly infused into the ileal lumen [7, 9] . The use of the non-metabolizable FA, α-bromopalmitate, which is a good inducer of L-FABP expression in this model, triggered the appearance of a strong L-FABP mRNA signal in both controls and PPARα-null mice ( Figure 5 ).
PPARδ/α agonist GW2433 triggers the induction of L-FABP mRNA in intestine from PPARα-null mice
Taken together, our results indicate that PPARα is not required for the bezafibrate-and LCFA-mediated inductions of the gene encoding L-FABP in the small intestine. Because PPARδ is highly expressed in this tissue (Figure 2) , and might bind to and activate the PPRE L-FABP sequence ( [14, 15] , and Figure 1 ), we hypothesized that the gene encoding L-FABP might be under the control of PPARδ in the small intestine. To examine this possibility, we compared the effect of the selective PPARα agonist GW7647 and the dual PPARδ\α agonist GW2433 [33] on L-FABP expression by using intestinal explants from wildtype and PPARα-deficient mice. This ex i o experiment allowed us to check the direct effect of a PPARδ agonist on the gene
Figure 6 Effects of agonists for PPARα (GW7647) and PPARδ (GW2433) on L-FABP mRNA levels in organ cultures of duodeno-jejunal (A) and ileal (B)
explants from PPARα + / + and PPARα − / − mice encoding L-FABP. Indeed, the dual PPARδ\α agonist GW2433 became a selective PPARδ agonist in explants from mice in which PPARα was lacking. As shown in Figure 6 (A), in duodenojejunal explants from wild-type mice, both the selective PPARα agonists GW7647 and GW2433 were able to increase the L-FABP mRNA levels. In contrast, and in spite of the high concentration of GW7647 used (1.5 µM; EC &! l 5 nM), the inductive effect was found only with GW2433 (1.5 µM; EC &! l 300 nM) in explants from PPARα-null mice ( Figure 6 ). To visualize this regulation better, the experiment was reproduced with ileal explants in which the L-FABP mRNA level was undectectable in the basal condition of culture. Only GW2433 was able to elicit a strong L-FABP mRNA signal in both PPARα +/+ and PPARα −/− mice ( Figure 6B ).
DISCUSSION
We have demonstrated previously that the gene encoding L-FABP is regulated transcriptionally both by bezafibrate and LCFAs in the liver and small intestine [6] [7] [8] [9] . The transfection results reported here provide the first functional evidence that this regulation involves direct interaction between the PPARs and a unique PPRE sequence located in the proximal part of the promoter : notably, transactivation of a CAT reporter gene is lost when the PPRE sequence (k67\k55) of the L-FABP promoter (k4000\j21) is mutated. Moreover, the short promoter fragment (k326\j21) is sufficient to reproduce fully the induction of the reporter gene in the presence of the three PPAR subtypes activated by specific pharmacological agonists.
PPARα and PPARδ are expressed predominantly in the liver and the small intestine respectively. To explore their respective contributions to the regulation of the gene encoding L-FABP in i o, we used PPARα-null mice. In the liver, in which L-FABP and PPARα are tightly co-localized in a periportal-to-perivenous gradient along the acinus in wild-type rodents [20, 34] , disruption of the gene encoding PPARα leads to a total loss of both bezafibrate-and FA-mediated induction of the gene encoding L-FABP (Figures 3 and 4) . Surprisingly, the increase in L-FABP mRNA levels, found classically in wild-type mice subjected to bezafibrate treatment or a high-fat diet, is maintained in the small intestine in spite of disruption of the gene for PPARα (Figures 3-5) . These results are the first demonstration that the regulation of L-FABP gene expression by fibrates and LCFAs might be independent of PPARα gene expression in the gut. The activation of mPPARδ by polyunsaturated fatty acid (PUFA) and bezafibrate, and its exclusive expression in the small intestine in PPARα-null mice, suggest strongly that the gene encoding L-FABP is under the control of PPARδ in this tissue. To verify this hypothesis, the use of a selective delta agonist was required. So far, the best synthetic ligands for PPARδ are GW2433 [33] and L165041 [35] . Unfortunately, these compounds also exhibit significant PPARα and PPARγ activity respectively [33, 35] . Nevertheless, the dual PPARδ\α agonist GW2433 was chosen because it becomes a selective PPARδ agonist in PPARα-null mice. The fact that GW2433-mediated induction of L-FABP expression is maintained in intestinal explants when PPARα is absent strongly suggests the involvement of PPARδ in this regulation. This new finding demonstrates that (1) PPARδ can act as fibrate\FA-activated receptor in tissues in which it is abundantly expressed and (2) L-FABP is a PPARδ target gene in the small intestine. Interestingly, a similar observation has been reported in the kidney, where the PPARα and PPARδ subtypes are also co-expressed. In this organ, the induction of acyl-CoA oxidase gene expression by the peroxisome proliferator di-2-ethylhexyl phthalate (DEHP) was maintained in PPARα-deficient mice [36] . The small intestine and the kidney exhibit complementary physiological functions because they are implicated in the absorption and reabsorption of nutrients respectively. The biological functions of PPARα and PPARγ are relatively well understood in rodents. PPARα is expressed abundantly in the liver, where it promotes lipid catabolism and peroxisome proliferation [11] . PPARγ, which is expressed predominantly in adipose tissue, regulates adipocyte differentiation and insulin sensitivity [37, 38] . In contrast, relatively little is known about the physiological function of PPARδ. PPARδ is found mainly in tissues characterized by a high lipid metabolism, such as the adipose tissue, heart, skeletal muscles, developing brain and small intestine [20] . In white adipose tissue, PPARδ induces the expression of early genes implicated in the initial steps of the adipocyte differentiation process, e.g. the fatty-acid translocase (FAT\CD36), adipocyte fatty-acid-binding protein (A-FABP) and acyl-CoA synthases (ACSs) [24] . In brain, ACS-2 might be a PPARδ target gene [39] . FAT\CD36 and A-FABP are plasma membrane and cytoplasmic lipid-binding proteins respectively, which bind LCFAs. They are believed to have a crucial role in the cellular uptake and trafficking of LCFAs. ACSs are intracellular enzymes that promote the synthesis of the acyl-CoA esters of FAs. By maintaining of a low concentration of LCFAs in the cytoplasm, ACSs create a concentration gradient that promotes LCFA entry into the cell. This unidirectional flux is reinforced by the lack of diffusion of acyl-CoA esters through the plasma membrane. PPARδ might therefore have a role in the modulation of LCFA flux within cells through a co-ordinate regulation of genes involved in both cellular LCFA uptake (FAT\CD36, A-FABP) and FA activation (ACSs). The intestinal results presented here support this hypothesis.
In the small intestine, the strongest expression of PPARδ is found at the major site of lipid absorption (i.e. the duodenojejunum segment). Moreover, PPARδ up-regulates the expression of L-FABP, a lipid-binding protein found abundantly in the enterocyte. From transfection studies in different cell lines, it seems that L-FABP increases cellular LCFA uptake and trafficking [40, 41] . L-FABP is also thought to have an indirect but essential role in the co-ordinated regulation of FA-responsive genes, through the modulation of the intracellular concentration of free LCFAs. These putative functions are supported by two observations. First, L-FABP exhibits a strong affinity for PUFA [1] , which are natural ligands for the PPARs [17] [18] [19] . Secondly, a linear correlation between L-FABP levels and PPARα activation was reported in nuclei from hepatocytes [4] . Thus L-FABP seems to be a cytosolic-nuclear shuttle protein implicated in the ligand activation of PPARα and therefore in the transcription of PPARα target genes in the liver. Because mouse PPARα and PPARδ have overlapping binding characteristics for PUFA, a similar mechanism could be envisaged in the small intestine. This function would be important in an organ whose physiological role is to ensure the efficient absorption of nutrients. Interestingly, several putative FA target genes expressed in the enterocyte are lipid-binding proteins (FAT\CD36, fatty-acid transport protein and L-FABP), or FA activators (ACSs). Therefore PPARδ-mediated regulation of the gene encoding L-FABP migh contribute to the regulation of intestinal absorption in response to changes in the lipid content of the diet through the co-ordinated regulation of genes involved in lipid transport and metabolism. A PPARδ-null mouse model was generated [42] . It might contribute to the establishment of the definitive proof for a specific function of PPARδ in the small intestine.
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